-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Large Drop in Short Interest
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Large Drop in Short Interest
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) was the recipient of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 154,900 shares, a decrease of 18.6% from the October 15th total of 190,300 shares. Based on an average daily volume of 75,200 shares, the days-to-cover ratio is presently 2.1 days. Currently, 1.5% of the company's shares are sold short.
Bluejay Diagnostics Stock Performance
Bluejay Diagnostics stock traded up $0.03 during trading on Tuesday, hitting $0.73. The company's stock had a trading volume of 52,876 shares, compared to its average volume of 54,507. The stock's fifty day moving average is $0.84 and its 200 day moving average is $1.03. Bluejay Diagnostics has a 1-year low of $0.61 and a 1-year high of $4.47.
Get Bluejay Diagnostics alerts:Institutional Investors Weigh In On Bluejay Diagnostics
A number of large investors have recently modified their holdings of BJDX. Millennium Management LLC acquired a new stake in shares of Bluejay Diagnostics in the second quarter valued at about $27,000. Virtu Financial LLC acquired a new stake in shares of Bluejay Diagnostics in the second quarter valued at about $45,000. Finally, Renaissance Technologies LLC acquired a new stake in shares of Bluejay Diagnostics in the second quarter valued at about $54,000. Institutional investors and hedge funds own 1.21% of the company's stock.
Bluejay Diagnostics Company Profile
(Get Rating)Bluejay Diagnostics, Inc, a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components.
Featured Articles
- Get a free copy of the StockNews.com research report on Bluejay Diagnostics (BJDX)
- Don't Chase Walmart Higher, Wait For Extra Low Prices
- Home Depot Results (and Institutions) Are A Catalyst For Lowe's?
- Three Penny Stocks Making Big Moves In November
- Agilent Remains In Buy Range Ahead Of Next Week's Q4 Report
- Wayfair Still Has Its Fair Share of Issues
Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) was the recipient of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 154,900 shares, a decrease of 18.6% from the October 15th total of 190,300 shares. Based on an average daily volume of 75,200 shares, the days-to-cover ratio is presently 2.1 days. Currently, 1.5% of the company's shares are sold short.
BlueJay診斷公司(納斯達克代碼:BJDX-GET Rating)是空頭股數10月份銷量大幅下降的接收方。截至10月31日,空頭股數共有154,900股,較10月15日的190,300股減少18.6%。以日均成交量75,200股計算,目前天數與回補比率為2.1天。目前,該公司1.5%的股票被賣空。
Bluejay Diagnostics Stock Performance
BlueJay診斷公司股票表現
Bluejay Diagnostics stock traded up $0.03 during trading on Tuesday, hitting $0.73. The company's stock had a trading volume of 52,876 shares, compared to its average volume of 54,507. The stock's fifty day moving average is $0.84 and its 200 day moving average is $1.03. Bluejay Diagnostics has a 1-year low of $0.61 and a 1-year high of $4.47.
BlueJay診斷公司的股票在週二的交易中上漲了0.03美元,達到0.73美元。該公司股票的成交量為52,876股,而其平均成交量為54,507股。該股的50日移動均線切入位為0.84美元,200日移動均線切入位為1.03美元。BlueJay Diagnostics的一年低點為0.61美元,一年高位為4.47美元。
Institutional Investors Weigh In On Bluejay Diagnostics
機構投資者參與Bluejay Diagnostics
A number of large investors have recently modified their holdings of BJDX. Millennium Management LLC acquired a new stake in shares of Bluejay Diagnostics in the second quarter valued at about $27,000. Virtu Financial LLC acquired a new stake in shares of Bluejay Diagnostics in the second quarter valued at about $45,000. Finally, Renaissance Technologies LLC acquired a new stake in shares of Bluejay Diagnostics in the second quarter valued at about $54,000. Institutional investors and hedge funds own 1.21% of the company's stock.
一些大型投資者最近調整了對BJDX的持股。Millennium Management LLC在第二季度收購了Bluejay Diagnostics的新股份,價值約2.7萬美元。Virtu Financial LLC在第二季度收購了Bluejay Diagnostics的新股份,價值約4.5萬美元。最後,復興科技有限責任公司在第二季度收購了Bluejay Diagnostics的新股份,價值約5.4萬美元。機構投資者和對衝基金持有該公司1.21%的股票。
Bluejay Diagnostics Company Profile
BlueJay診斷公司簡介
Bluejay Diagnostics, Inc, a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components.
BlueJay診斷公司是一家診斷公司,在美國開發和銷售用於分診、診斷和監測疾病進展的患者產品。它正在開發一個技術平臺,包括使用非接觸式離心力協調血液處理、生物標記物分離和免疫分析準備的SYMPHONY熒光免疫分析儀;以及包括試劑和組件的SYMPHONY卡片庫。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on Bluejay Diagnostics (BJDX)
- Don't Chase Walmart Higher, Wait For Extra Low Prices
- Home Depot Results (and Institutions) Are A Catalyst For Lowe's?
- Three Penny Stocks Making Big Moves In November
- Agilent Remains In Buy Range Ahead Of Next Week's Q4 Report
- Wayfair Still Has Its Fair Share of Issues
- 免費獲取StockNews.com關於Bluejay診斷的研究報告(BJDX)
- 不要追逐沃爾瑪更高,等待超低價格
- 家得寶的業績(和機構)是勞氏的催化劑嗎?
- 三隻細價股在11月大動干戈
- 安捷倫在下週第四季度報告發布前仍在買入區間
- WayFair仍有其公平份額的問題
Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
接收Bluejay診斷日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收Bluejay Diagnostics和相關公司的最新新聞和分析師評級的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧